Wyeth FluMist Draft Label Will Be Reviewed By CDC Cmte. To Speed Coverage

Wyeth has obtained permission from FDA to provide draft labeling for its intranasal flu vaccine FluMist to CDC's Advisory Committee on Immunization Practices in order to speed a coverage decision once the product is approved